Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 15.00
  • 52 Week Low: 8.00
  • Currency: UK Pounds
  • Shares Issued: 661.22m
  • Volume: 195,218
  • Market Cap: £64.47m

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1132.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 54.6 n/a
Pr/Book 41.4  
Latest F'cast
Revenue 29.1% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OBI Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 2.57 (50.08) (63.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 0.64 (19.37) (10.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1.20 (14.41) (0.07)¢ n/a n/a n/a n/a 0.0%
31-Dec-24 2.05 (19.10) (0.07)¢ n/a n/a n/a n/a 0.0%
31-Dec-25 2.65 (29.52) (0.06)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OBI Company Announcements

LANTERN Safety Results Presented at IDWeek 28-Oct-2026 07:00 RNS
Holding(s) in Company 26-Oct-2026 17:02 RNS
Ottawa Heart Institute Reduces CABG SSIs by 51.5% 23-Oct-2026 07:00 RNS

OBI ShareCast News

Ondine Provides Update on US Phase 3 Pivotal Study 10-Mar-2026 ShareCast
Ondine expands use of Steriwave in Spain 22-Jan-2026 ShareCast
Finalist for 2nd National Award for SSI reduction 23-Dec-2025 ShareCast

Latest OBI Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

OBI Market Data

Currency UK Pounds
Share Price 9.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 15.00
52 Week Low 8.00
Volume 195,218
Shares Issued 661.22m
Market Cap £64.47m

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
63.38% below the market average63.38% below the market average63.38% below the market average63.38% below the market average63.38% below the market average
36.59% below the sector average36.59% below the sector average36.59% below the sector average36.59% below the sector average36.59% below the sector average
Price Trend
52.04% below the market average52.04% below the market average52.04% below the market average52.04% below the market average52.04% below the market average
6.98% below the sector average6.98% below the sector average6.98% below the sector average6.98% below the sector average6.98% below the sector average
Income Not Available
Growth
54.17% above the market average54.17% above the market average54.17% above the market average54.17% above the market average54.17% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

OBI Dividends

No dividends found

Trades for 30-Oct-2026

Time Volume / Share Price
16:35 25,000 @ 9.75p
16:35 15,000 @ 9.75p
16:35 10,000 @ 9.75p
15:52 1,000 @ 9.63p
14:00 5,395 @ 9.50p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page